ILMN up +2.17% percent Today $ILMN High is at 191.56 and the Low 186.92 with current volume of 242,091.
Recent News posted below.
Illumina Inc ILMN other info.
http://investorshangout.com/Illumina-ILMN-54443/
ILMN Illumina Inc Recent Headline News
Alnylam Adds Hepatic Infectious Disease Drugs to Pipeline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 4:40PM CST
Alnylam (ALNY) expands its hepatic infectious disease pipeline with two new candidates, ALN-HDV (hepatitis delta viral) and ALN-PDL (chronic liver).
BIIB: 320.91 (-0.11), ALNY: 102.35 (+2.50), ILMN: 190.70 (+3.78), AMAG: 34.96 (+0.03)
Brand Timbre Develops Audio-Identity Platform for World's Largest Genomics Company
Marketwired - Wed Nov 12, 6:00AM CST
Brand Timbre LLC, a strategic sonic branding agency, has completed work on the first stage of a comprehensive audio-branding initiative for Illumina Inc. Illumina is an industry-leading life-sciences company that designs, develops and manufactures DNA and genetics sequencing machines used in labs throughout the world. Brand Timbre's multi-phase project includes an audio-branding strategy, an audio-identity profile that defines Illumina's sound, an audio logo, and product-sonification (sound design) assets for Illumina's sequencing instruments.
ILMN: 190.70 (+3.78)
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver
PR Newswire - Tue Nov 11, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for ACHN, CLDX, KNDI, ILMN and AMD.
KNDI: 13.67 (-1.08), AMD: 2.72 (+0.01), ACHN: 14.63 (-0.22), CLDX: 15.13 (+0.32), ILMN: 190.70 (+3.78)
Achillion Pharmaceuticals (ACHN) Looks Strong: Stock Up 27.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 7:44AM CST
Achillion Pharmaceuticals (ACHN) was a big mover last session, as the company saw its shares surge a little over 27% on the day
HSKA: 16.00 (unch), ACHN: 14.63 (-0.22), ILMN: 190.70 (+3.78), AFFX: 9.97 (+0.19)
Global Preimplantation Genetic Diagnosis (PGD for Chromosomal Aberrations, Aneuploidy Screening, Gender Selection, Single Gene Disorders, HLA Typing and X-linked Diseases) Market - Trends and Forecast to 2020
M2 - Tue Nov 11, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/sm76mf/preimplantation) has announced the addition of the "Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. Since the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader range of indications due to advancements in the medical technology. These indications include chromosomal aberrations, genetic abnormalities, gender selection, HLA typing, X-linked diseases and single gene diseases. Demand for PGD is continuously increasing in patients who undergo IVF in the hope that it would improve the probability of live birth and reduce the chances of disabilities and genetic disorders in the offspring. This report provides in-depth analysis of the preimplantation genetic diagnosis market and its test types across various regions. Stakeholders in the report include diagnostic laboratories that provide PGD services, companies involved in the production of diagnosis kits and sequencers for PGD, and prospective market players planning to enter the market. The report comprises executive summary, which offers a market snapshot that covers the overall information about various types of tests in the PGD market. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Preimplantation Genetic Diagnosis Market Overview Chapter 4 Global Preimplantation Genetic Diagnosis Market, by Test Type Chapter 5 Preimplantation Genetic Diagnosis Market, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles Companies Mentioned: - Genea Ltd. - Genesis Genetics - Illumina, Inc. - Laboratory Corporation of America Holdings (LabCorp) - Natera, Inc. - PerkinElmer, Inc. - Quest Diagnostics, Inc. - Reproductive Genetics Institute - Reprogenetics LLC For more information visit http://www.researchandmarkets.com/research/sm...plantation
DGX: 63.64 (+0.75), LH: 100.07 (-0.63), ILMN: 190.70 (+3.78), PKI: 43.76 (-0.02)
Winning Stock Picking Ideas from Last Week's Jobs Report - Screen of the Week
Kevin Matras - Zacks Investment Research - Tue Nov 11, 3:18AM CST
Winning Stock Picking Ideas from Last Week's Jobs Report - Screen of the Week
CST: 41.27 (+0.87), JACK: 72.38 (+0.07), IHS: 131.03 (+0.17), ILMN: 190.70 (+3.78)
Big Cap 20 Stuffed With Medical Names
at Investor's Business Daily - Mon Nov 10, 6:34PM CST
Nine of the Big Cap 20 names this week are in medical-related fields, revealing that the leadership among these names over the past few years has continued despite October's correction, which whittled more than 10% off the Nasdaq. Alexion...
ABC: 89.19 (+0.48), VRX: 132.89 (+1.80), ALXN: 194.26 (+0.57), AMGN: 161.78 (-0.15), MYL: 55.12 (+1.32), ILMN: 190.70 (+3.78), CELG: 108.74 (+0.49)
A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 37.33 (+0.13), HD: 99.14 (+0.65), AKRX: 37.01 (+1.58), ILMN: 190.70 (+3.78)
'Mad Money' Lightning Round: Pull the Trigger on Baxter
at The Street - Thu Nov 06, 5:00AM CST
Cramer likes Illumina but isn't a big fan of GEO Group or AK Steel Holdings.
RIG: 26.76 (-0.32), GEO: 39.78 (-0.21), TMO: 118.46 (-0.05), ESV: 38.59 (-0.68), NUE: 53.86 (+0.59), BAX: 72.10 (+0.77), ILMN: 190.70 (+3.78), AKS: 6.58 (+0.34), OXY: 86.95 (-1.64)
Cramer's Lightning Round - Baxter May Go Faster (11/5/14)
SA Editor Miriam Metzinger - Seeking Alpha - Thu Nov 06, 4:59AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday November 5. Bullish Calls: Baxter (NYSE: BAX ): "I think it is finally starting to run. It has lagged, but it is time to pull the...
RIG: 26.76 (-0.32), GEO: 39.78 (-0.21), TMO: 118.46 (-0.05), NUE: 53.86 (+0.59), BAX: 72.10 (+0.77), ILMN: 190.70 (+3.78), AKS: 6.58 (+0.34), OXY: 86.97 (-1.62)
Jim Cramer's 'Mad Money' Recap: What a Republican Senate Means for Stocks
at The Street - Wed Nov 05, 7:20PM CST
It's bullish news but you can't buy just anything, Cramer says.
ACT: 244.48 (+3.86), LMT: 188.58 (+1.71), XOM: 94.84 (-0.54), ILMN: 190.70 (+3.78), AKS: 6.58 (+0.34), KORS: 71.45 (+0.45), PAYX: 47.65 (+0.16), RIG: 26.76 (-0.32), EOG: 96.27 (-1.29), COST: 137.76 (+0.86), TWTR: 43.00 (+0.46), OXY: 86.97 (-1.62), KO: 43.03 (+0.32), SEAS: 16.91 (+0.06), TMO: 118.46 (-0.05), NUE: 53.86 (+0.59), TRIP: 71.29 (+0.91), DISCA: 31.99 (+0.13), CHUY: 22.37 (-0.12), LB: 77.09 (-0.85), GEO: 39.78 (-0.21), ESV: 38.59 (-0.68), MPC: 93.71 (-1.30), BAX: 72.10 (+0.77), MRK: 59.80 (+0.49), EXPE: 86.92 (-0.19), STI: 39.73 (-0.12)
SmarTrend Watching for Potential Rebound in Shares of Illumina After 2.63% Loss
Comtex SmarTrend(R) - Wed Nov 05, 4:33PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $184.83 to a high of $194.13. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $189.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 190.70 (+3.78)
Illumina Falls 2.63% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Nov 05, 4:33PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $184.83 to a high of $194.13. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $189.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 190.70 (+3.78)
Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 49.31 (-0.08), MNST: 108.63 (+0.72), SWKS: 61.19 (+0.20), GMCR: 152.59 (-0.14), ILMN: 190.70 (+3.78), WSM: 69.04 (+0.27), NXPI: 74.00 (+0.60), CELG: 108.74 (+0.49), HAIN: 107.50 (+0.81), AGN: 197.50 (+0.99), CNC: 97.34 (-0.16), V: 251.14 (-0.81), CALM: 41.77 (+0.03), JAZZ: 175.77 (+2.24), ALXN: 194.26 (+0.57), LOW: 58.65 (+0.43), ULTA: 124.69 (-0.35), MA: 84.25 (-0.10), AVGO: 87.47 (+0.42), PETM: 73.03 (+0.26)
Quarterly Financial Results and Product Approval - Research Reports on Pacira, PAREXEL, WellPoint, Illumina and St. Jude Medical
PR Newswire - Tue Nov 04, 8:00AM CST
Today, Analysts Review released its research reports regarding Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), PAREXEL International Corporation (NASDAQ: PRXL), WellPoint Inc. (NYSE: WLP), Illumina, Inc. (NASDAQ: ILMN) and St. Jude Medical, Inc. (NYSE: STJ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7670-100free.
PRXL: 56.98 (+0.78), STJ: 66.07 (+0.39), ILMN: 190.70 (+3.78), PCRX: 91.39 (+1.98), WLP: 127.57 (+0.93)
Geron Corporation (GERN) Looks Strong: Stock Up 25.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:44AM CST
Geron Corporation (GERN) was a big mover last session, as the company saw its shares surge nearly 26% on the day
MDVN: 107.23 (+0.90), ONCY: 0.81 (-0.03), GERN: 2.39 (+0.02), ILMN: 190.70 (+3.78)
Big Cap 20: Health Care, Tech Stocks Rule The Roost
at Investor's Business Daily - Mon Nov 03, 4:58PM CST
Large-cap stocks often get labeled as boring because of overall sluggish price action, but the latest IBD Big Cap 20 list of leading large-cap growth is far from boring. Recent health care-related names like Alexion Pharmaceuticals (ALXN), Illumina...
LNKD: 233.90 (+2.77), ALXN: 194.26 (+0.57), ILMN: 190.70 (+3.78), REGN: 399.11 (-2.00), CRM: 64.02 (+0.25), CELG: 108.74 (+0.49)
Was That The Final Growth Stock Shakeout?
Cabot - Seeking Alpha - Mon Nov 03, 10:23AM CST
By Michael Cintolo, Chief Analyst, Cabot Market Letter Back in the fall of 1999, we attended a conference where one chart-focused investor gave a presentation we still remember to this day. Most investors remember 1999 as an endless party, but the...
SPY: 204.73 (+0.77), QQQ: 103.19 (+0.73), DIA: 176.82 (+0.78), ILMN: 190.70 (+3.78), IWM: 118.18 (+0.28), CELG: 108.74 (+0.49)
Prosensa Holding N.V. (RNA) Jumps: Stock Moves Up 9.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:39AM CST
Prosensa Holding N.V. (RNA) was a big mover last session, as its shares rose nearly 10% on the day.
MDVN: 107.23 (+0.90), MACK: 8.49 (-0.06), RNA: 11.79 (+0.04), ILMN: 190.70 (+3.78)
Recent News posted below.
Illumina Inc ILMN other info.
http://investorshangout.com/Illumina-ILMN-54443/
ILMN Illumina Inc Recent Headline News
Alnylam Adds Hepatic Infectious Disease Drugs to Pipeline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 12, 4:40PM CST
Alnylam (ALNY) expands its hepatic infectious disease pipeline with two new candidates, ALN-HDV (hepatitis delta viral) and ALN-PDL (chronic liver).
BIIB: 320.91 (-0.11), ALNY: 102.35 (+2.50), ILMN: 190.70 (+3.78), AMAG: 34.96 (+0.03)
Brand Timbre Develops Audio-Identity Platform for World's Largest Genomics Company
Marketwired - Wed Nov 12, 6:00AM CST
Brand Timbre LLC, a strategic sonic branding agency, has completed work on the first stage of a comprehensive audio-branding initiative for Illumina Inc. Illumina is an industry-leading life-sciences company that designs, develops and manufactures DNA and genetics sequencing machines used in labs throughout the world. Brand Timbre's multi-phase project includes an audio-branding strategy, an audio-identity profile that defines Illumina's sound, an audio logo, and product-sonification (sound design) assets for Illumina's sequencing instruments.
ILMN: 190.70 (+3.78)
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Kandi Technologies, Illumina and Advanced Micro Devices Released By InvestorsObserver
PR Newswire - Tue Nov 11, 8:31AM CST
InvestorsObserver issues critical PriceWatch Alerts for ACHN, CLDX, KNDI, ILMN and AMD.
KNDI: 13.67 (-1.08), AMD: 2.72 (+0.01), ACHN: 14.63 (-0.22), CLDX: 15.13 (+0.32), ILMN: 190.70 (+3.78)
Achillion Pharmaceuticals (ACHN) Looks Strong: Stock Up 27.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 11, 7:44AM CST
Achillion Pharmaceuticals (ACHN) was a big mover last session, as the company saw its shares surge a little over 27% on the day
HSKA: 16.00 (unch), ACHN: 14.63 (-0.22), ILMN: 190.70 (+3.78), AFFX: 9.97 (+0.19)
Global Preimplantation Genetic Diagnosis (PGD for Chromosomal Aberrations, Aneuploidy Screening, Gender Selection, Single Gene Disorders, HLA Typing and X-linked Diseases) Market - Trends and Forecast to 2020
M2 - Tue Nov 11, 4:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/sm76mf/preimplantation) has announced the addition of the "Preimplantation Genetic Diagnosis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. Since the last two decades, preimplantation genetic diagnosis (PGD) has been used to detect chromosomal aneuploidy in low prognosis patients who undergo in-vitro fertilization (IVF). PGD is now being used to detect a broader range of indications due to advancements in the medical technology. These indications include chromosomal aberrations, genetic abnormalities, gender selection, HLA typing, X-linked diseases and single gene diseases. Demand for PGD is continuously increasing in patients who undergo IVF in the hope that it would improve the probability of live birth and reduce the chances of disabilities and genetic disorders in the offspring. This report provides in-depth analysis of the preimplantation genetic diagnosis market and its test types across various regions. Stakeholders in the report include diagnostic laboratories that provide PGD services, companies involved in the production of diagnosis kits and sequencers for PGD, and prospective market players planning to enter the market. The report comprises executive summary, which offers a market snapshot that covers the overall information about various types of tests in the PGD market. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Preimplantation Genetic Diagnosis Market Overview Chapter 4 Global Preimplantation Genetic Diagnosis Market, by Test Type Chapter 5 Preimplantation Genetic Diagnosis Market, by Geography Chapter 6 Recommendations Chapter 7 Company Profiles Companies Mentioned: - Genea Ltd. - Genesis Genetics - Illumina, Inc. - Laboratory Corporation of America Holdings (LabCorp) - Natera, Inc. - PerkinElmer, Inc. - Quest Diagnostics, Inc. - Reproductive Genetics Institute - Reprogenetics LLC For more information visit http://www.researchandmarkets.com/research/sm...plantation
DGX: 63.64 (+0.75), LH: 100.07 (-0.63), ILMN: 190.70 (+3.78), PKI: 43.76 (-0.02)
Winning Stock Picking Ideas from Last Week's Jobs Report - Screen of the Week
Kevin Matras - Zacks Investment Research - Tue Nov 11, 3:18AM CST
Winning Stock Picking Ideas from Last Week's Jobs Report - Screen of the Week
CST: 41.27 (+0.87), JACK: 72.38 (+0.07), IHS: 131.03 (+0.17), ILMN: 190.70 (+3.78)
Big Cap 20 Stuffed With Medical Names
at Investor's Business Daily - Mon Nov 10, 6:34PM CST
Nine of the Big Cap 20 names this week are in medical-related fields, revealing that the leadership among these names over the past few years has continued despite October's correction, which whittled more than 10% off the Nasdaq. Alexion...
ABC: 89.19 (+0.48), VRX: 132.89 (+1.80), ALXN: 194.26 (+0.57), AMGN: 161.78 (-0.15), MYL: 55.12 (+1.32), ILMN: 190.70 (+3.78), CELG: 108.74 (+0.49)
A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 37.33 (+0.13), HD: 99.14 (+0.65), AKRX: 37.01 (+1.58), ILMN: 190.70 (+3.78)
'Mad Money' Lightning Round: Pull the Trigger on Baxter
at The Street - Thu Nov 06, 5:00AM CST
Cramer likes Illumina but isn't a big fan of GEO Group or AK Steel Holdings.
RIG: 26.76 (-0.32), GEO: 39.78 (-0.21), TMO: 118.46 (-0.05), ESV: 38.59 (-0.68), NUE: 53.86 (+0.59), BAX: 72.10 (+0.77), ILMN: 190.70 (+3.78), AKS: 6.58 (+0.34), OXY: 86.95 (-1.64)
Cramer's Lightning Round - Baxter May Go Faster (11/5/14)
SA Editor Miriam Metzinger - Seeking Alpha - Thu Nov 06, 4:59AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday November 5. Bullish Calls: Baxter (NYSE: BAX ): "I think it is finally starting to run. It has lagged, but it is time to pull the...
RIG: 26.76 (-0.32), GEO: 39.78 (-0.21), TMO: 118.46 (-0.05), NUE: 53.86 (+0.59), BAX: 72.10 (+0.77), ILMN: 190.70 (+3.78), AKS: 6.58 (+0.34), OXY: 86.97 (-1.62)
Jim Cramer's 'Mad Money' Recap: What a Republican Senate Means for Stocks
at The Street - Wed Nov 05, 7:20PM CST
It's bullish news but you can't buy just anything, Cramer says.
ACT: 244.48 (+3.86), LMT: 188.58 (+1.71), XOM: 94.84 (-0.54), ILMN: 190.70 (+3.78), AKS: 6.58 (+0.34), KORS: 71.45 (+0.45), PAYX: 47.65 (+0.16), RIG: 26.76 (-0.32), EOG: 96.27 (-1.29), COST: 137.76 (+0.86), TWTR: 43.00 (+0.46), OXY: 86.97 (-1.62), KO: 43.03 (+0.32), SEAS: 16.91 (+0.06), TMO: 118.46 (-0.05), NUE: 53.86 (+0.59), TRIP: 71.29 (+0.91), DISCA: 31.99 (+0.13), CHUY: 22.37 (-0.12), LB: 77.09 (-0.85), GEO: 39.78 (-0.21), ESV: 38.59 (-0.68), MPC: 93.71 (-1.30), BAX: 72.10 (+0.77), MRK: 59.80 (+0.49), EXPE: 86.92 (-0.19), STI: 39.73 (-0.12)
SmarTrend Watching for Potential Rebound in Shares of Illumina After 2.63% Loss
Comtex SmarTrend(R) - Wed Nov 05, 4:33PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $184.83 to a high of $194.13. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $189.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 190.70 (+3.78)
Illumina Falls 2.63% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Nov 05, 4:33PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $184.83 to a high of $194.13. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $189.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 190.70 (+3.78)
Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 49.31 (-0.08), MNST: 108.63 (+0.72), SWKS: 61.19 (+0.20), GMCR: 152.59 (-0.14), ILMN: 190.70 (+3.78), WSM: 69.04 (+0.27), NXPI: 74.00 (+0.60), CELG: 108.74 (+0.49), HAIN: 107.50 (+0.81), AGN: 197.50 (+0.99), CNC: 97.34 (-0.16), V: 251.14 (-0.81), CALM: 41.77 (+0.03), JAZZ: 175.77 (+2.24), ALXN: 194.26 (+0.57), LOW: 58.65 (+0.43), ULTA: 124.69 (-0.35), MA: 84.25 (-0.10), AVGO: 87.47 (+0.42), PETM: 73.03 (+0.26)
Quarterly Financial Results and Product Approval - Research Reports on Pacira, PAREXEL, WellPoint, Illumina and St. Jude Medical
PR Newswire - Tue Nov 04, 8:00AM CST
Today, Analysts Review released its research reports regarding Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), PAREXEL International Corporation (NASDAQ: PRXL), WellPoint Inc. (NYSE: WLP), Illumina, Inc. (NASDAQ: ILMN) and St. Jude Medical, Inc. (NYSE: STJ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7670-100free.
PRXL: 56.98 (+0.78), STJ: 66.07 (+0.39), ILMN: 190.70 (+3.78), PCRX: 91.39 (+1.98), WLP: 127.57 (+0.93)
Geron Corporation (GERN) Looks Strong: Stock Up 25.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:44AM CST
Geron Corporation (GERN) was a big mover last session, as the company saw its shares surge nearly 26% on the day
MDVN: 107.23 (+0.90), ONCY: 0.81 (-0.03), GERN: 2.39 (+0.02), ILMN: 190.70 (+3.78)
Big Cap 20: Health Care, Tech Stocks Rule The Roost
at Investor's Business Daily - Mon Nov 03, 4:58PM CST
Large-cap stocks often get labeled as boring because of overall sluggish price action, but the latest IBD Big Cap 20 list of leading large-cap growth is far from boring. Recent health care-related names like Alexion Pharmaceuticals (ALXN), Illumina...
LNKD: 233.90 (+2.77), ALXN: 194.26 (+0.57), ILMN: 190.70 (+3.78), REGN: 399.11 (-2.00), CRM: 64.02 (+0.25), CELG: 108.74 (+0.49)
Was That The Final Growth Stock Shakeout?
Cabot - Seeking Alpha - Mon Nov 03, 10:23AM CST
By Michael Cintolo, Chief Analyst, Cabot Market Letter Back in the fall of 1999, we attended a conference where one chart-focused investor gave a presentation we still remember to this day. Most investors remember 1999 as an endless party, but the...
SPY: 204.73 (+0.77), QQQ: 103.19 (+0.73), DIA: 176.82 (+0.78), ILMN: 190.70 (+3.78), IWM: 118.18 (+0.28), CELG: 108.74 (+0.49)
Prosensa Holding N.V. (RNA) Jumps: Stock Moves Up 9.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:39AM CST
Prosensa Holding N.V. (RNA) was a big mover last session, as its shares rose nearly 10% on the day.
MDVN: 107.23 (+0.90), MACK: 8.49 (-0.06), RNA: 11.79 (+0.04), ILMN: 190.70 (+3.78)
